» Articles » PMID: 23513231

Obesity is a Risk Factor for Thyroid Cancer in a Large, Ultrasonographically Screened Population

Overview
Specialty Endocrinology
Date 2013 Mar 21
PMID 23513231
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Obesity is a well-known risk factor for many cancers, including those of the esophagus, colon, kidney, breast, and skin. However, there are few reports on the relationship between obesity and thyroid cancer. We conducted this study to determine whether obesity is a risk factor for thyroid cancer by systematically screening a selected population by ultrasonography.

Design And Methods: We obtained data from 15,068 subjects that underwent a routine health checkup from 2007 to 2008 at the Health Screening and Promotion Center of Asan Medical Center. Thyroid ultrasonography was included in the checkup, and suspicious nodules were examined by ultrasonography-guided aspiration. Those with a history of thyroid disease or family history of thyroid cancer were excluded from this study.

Results: In total, 15,068 subjects, 8491 men and 6577 women, were screened by thyroid ultrasonography. Fine-needle aspiration cytology was performed in 1427 of these patients based on the predefined criteria and thyroid cancer was diagnosed in 267 patients. The prevalence of thyroid cancer in women was associated with a high BMI (per 5 kg/m(2) increase) (odds ratios (OR)=1.63, 95% CI 1.24-2.10, P<0.001), after adjustment for age, smoking status, and TSH levels. There was no positive correlation between the prevalence of thyroid cancer in men and a high BMI (OR=1.16, 95% CI 0.85-1.57, P=0.336). There was no association between age, fasting serum insulin, or basal TSH levels and thyroid cancer in either gender.

Conclusions: Obesity was associated with a higher prevalence of thyroid cancer in women when evaluated in a routine health checkup setting. This association between risk factor and disease was unrelated to serum insulin and TSH levels. Additional studies are needed to understand the mechanism(s) behind the association of obesity with thyroid cancer risk.

Citing Articles

Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis?.

Pejman Sani M, Mohseni S, Samimi H, Nasiri S, Fallahi B, Mohajeri-Tehrani M J Diabetes Metab Disord. 2025; 24(1):68.

PMID: 39980844 PMC: 11836260. DOI: 10.1007/s40200-025-01581-0.


Investigating papillary thyroid cancer risk factors among women living at the central region of Iran: a case-control study.

Ghoshouni H, Hosseini S, Ghadiri-Anari A, Azizi R, Rahmanian M, Hazar N BMC Endocr Disord. 2025; 25(1):12.

PMID: 39819284 PMC: 11737264. DOI: 10.1186/s12902-025-01833-3.


The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor?.

Mele C, De Marchi L, Marsan G, Zavattaro M, Mauri M, Aluffi Valletti P Biomedicines. 2024; 12(9).

PMID: 39335476 PMC: 11428425. DOI: 10.3390/biomedicines12091962.


Analysis of risk factors for papillary thyroid carcinoma and the association with thyroid function indicators.

Liu J, Feng Z, Gao R, Liu P, Meng F, Fan L Front Endocrinol (Lausanne). 2024; 15:1429932.

PMID: 39286267 PMC: 11402740. DOI: 10.3389/fendo.2024.1429932.


Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies.

Mohanty A, Afkhami M, Reyes A, Pharaon R, Yin H, Li H J Immunother Cancer. 2024; 12(7).

PMID: 39074963 PMC: 11288153. DOI: 10.1136/jitc-2023-008505.